- Home
- IBP vs RVMD Comparison
IBP vs RVMD Comparison
Compare IBP & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBP
- RVMD
- Stock Information
- Founded
- IBP 1977
- RVMD 2014
- Country
- IBP United States
- RVMD United States
- Employees
- IBP N/A
- RVMD N/A
- Industry
- IBP Homebuilding
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IBP Consumer Discretionary
- RVMD Health Care
- Exchange
- IBP Nasdaq
- RVMD Nasdaq
- Market Cap
- IBP 7.4B
- RVMD 7.5B
- IPO Year
- IBP 2014
- RVMD 2020
- Fundamental
- Price
- IBP $260.74
- RVMD $46.20
- Analyst Decision
- IBP Hold
- RVMD Strong Buy
- Analyst Count
- IBP 10
- RVMD 16
- Target Price
- IBP $220.88
- RVMD $73.56
- AVG Volume (30 Days)
- IBP 440.4K
- RVMD 2.0M
- Earning Date
- IBP 11-06-2025
- RVMD 11-05-2025
- Dividend Yield
- IBP 1.23%
- RVMD N/A
- EPS Growth
- IBP 0.34
- RVMD N/A
- EPS
- IBP 8.99
- RVMD N/A
- Revenue
- IBP $2,955,900,000.00
- RVMD N/A
- Revenue This Year
- IBP $0.30
- RVMD N/A
- Revenue Next Year
- IBP $2.03
- RVMD $387.56
- P/E Ratio
- IBP $28.86
- RVMD N/A
- Revenue Growth
- IBP 3.44
- RVMD N/A
- 52 Week Low
- IBP $150.83
- RVMD $29.17
- 52 Week High
- IBP $280.00
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- IBP 51.90
- RVMD 76.18
- Support Level
- IBP $263.55
- RVMD $39.73
- Resistance Level
- IBP $274.77
- RVMD $41.60
- Average True Range (ATR)
- IBP 8.19
- RVMD 1.86
- MACD
- IBP -3.04
- RVMD 0.90
- Stochastic Oscillator
- IBP 32.35
- RVMD 91.29
About IBP Installed Building Products Inc.
Installed Building Products Inc is an insulation installer serving the residential new construction market and are also a diversified installer of complementary building products, including waterproofing, fire-stopping and fireproofing, garage doors, rain gutters, window blinds, shower doors, closet shelving, mirrors and other products throughout the United States. The company installs fiberglass insulation, spray foam insulation, and cellulose insulation. The company has three operating segments consisting of Installation, Manufacturing and Distribution operations. Majority of revenue is derived from Installation segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.